Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1938]
News [3134]
Articles [127]
Editorials [3]
Conferences [119]
elearning [13]
Encouraging early results with GS-9973 for CLL and NHL
Dr Jeff Sharman- US Oncology, Eugene, Oregon
Encouraging early results with GS-9973 for CLL and NHL ( Dr Jeff Sharman- US Oncology, Eugene, Oregon )
18 Dec 2013
Role of Bcl-2 family in lymphoid malignancies
Prof Andreas Strasser - University of Melbourne, Melbourne, Australia
Role of Bcl-2 family in lymphoid malignancies ( Prof Andreas Strasser - University of Melbourne, Melbourne, Australia )
18 Dec 2013
FLT3-ITD positive acute myeloid leukaemia
Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
FLT3-ITD positive acute myeloid leukaemia ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
18 Dec 2013
PI3K-delta inhibitor idelalisib success in CLL
Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA
PI3K-delta inhibitor idelalisib success in CLL ( Dr Jennifer Brown - Dana-Farber Cancer Institute, Boston, USA )
18 Dec 2013
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for...
Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille...
Benefit of lenalidomide and low-dose dexamethasone over standard therapy for multiple myeloma ( Dr Thierry Facon - Centre Hospitalier Régional Universitaire de Lille, Lille, France )
18 Dec 2013
T cell immunotherapy for leukaemia in preclinical setting
Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA
T cell immunotherapy for leukaemia in preclinical setting ( Dr Michael Kalos - University of Pennsylvania, Philadelphia, USA )
17 Dec 2013
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia...
Dr Richard Furman - New York Weill Cornell Medical Center, USA
Idelalisib and rituximab for previously treated chronic lymphocytic leukaemia (CLL) ( Dr Richard Furman - New York Weill Cornell Medical Center, USA )
17 Dec 2013
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia...
Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA
Gemtuzumab improves event free survival for paediatric acute myeloid leukaemia (AML) ( Dr Alan Gamis - University of Missouri-Kansas City School of Medicine, USA )
17 Dec 2013
Comment: Transplantation and short telomeres increase the risk of cognitive...
Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA
Comment: Transplantation and short telomeres increase the risk of cognitive impairment ( Dr Jeffrey Miller - University of Minnesota, Minneapolis, USA )
17 Dec 2013
Equality of access to transplant for ethnic minority patients
Dr Robert Lown - Royal Marsden Hospital, London, UK
Equality of access to transplant for ethnic minority patients ( Dr Robert Lown - Royal Marsden Hospital, London, UK )
17 Dec 2013
New agents in CLL
Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA
New agents in CLL ( Dr Jacqueline Barrientos - LIJ Medical Center, New York, USA )
13 Dec 2013
Full-intensity transplantation and short telomeres increase risk of cognitive...
Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA
Full-intensity transplantation and short telomeres increase risk of cognitive impairment after allogeneic haematopoietic cell transplantation ( Dr Smita Bhatia - City of Hope National Medical Center, Duarte, USA )
13 Dec 2013

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation